Kosuke Hamada
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade.
Recurrence Risk Stratification in Clear Cell Renal Cell Carcinoma Using TNM 2017 and WHO/ISUP Grade.
Journal: Anticancer research
Published: February 13, 2026
Robot-assisted laparoscopic radical nephrectomy for renal cell carcinoma with direct colon invasion and concomitant inferior vena cava tumor thrombus: A case report.
Journal: Urology case reports
Published: August 15, 2025
Laparoscopic Retroperitoneal Removal of an Anteriorly Migrated Interbody Cage Following Posterior Lumbar Interbody Fusion: A Case Report.
Journal: IJU case reports
Published: June 18, 2025
Surgical Outcomes of the Non-renorrhaphy Technique During Robot-Assisted Partial Nephrectomy for Highly Complex Renal Tumors (RENAL Score ≥ 10).
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: April 03, 2025
Doppler ultrasonography as a screening test for the detection of asymptomatic renal artery pseudoaneurysms following partial nephrectomy: A 15-year single-institution experience.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: February 06, 2023
De novo large-cell neuroendocrine carcinoma of the prostate: A case report and literature review.
Journal: IJU case reports
Published: April 04, 2022
Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: August 09, 2021
External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer.
Journal: International journal of clinical oncology
Published: March 25, 2021
Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study.
Journal: International journal of clinical oncology
Published: December 29, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026